share_log

Canaccord Genuity Maintains Hold on Definitive Healthcare, Lowers Price Target to $8

Canaccord Genuity Maintains Hold on Definitive Healthcare, Lowers Price Target to $8

Canaccord Genuity继续持有最终医疗保健,将目标股价下调至8美元
Benzinga ·  05/08 12:41

Canaccord Genuity analyst David Hynes maintains Definitive Healthcare (NASDAQ:DH) with a Hold and lowers the price target from $10 to $8.

Canaccord Genuity分析师David Hynes 维持Definitive Healthcare(纳斯达克:DH)的持有评级,并将价格目标从10美元下调至8美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发